[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$ostx
$OSTX is seeing a significant surge in engagements, up XXXXXX% from the previous week, driven by discussions around its OST-HER2 therapy and upcoming clinical trial meetings. The company is also preparing for a spin-off of its animal health division.
About $ostx
$OSTX is a cryptocurrency and a clinical-stage biotech company focused on developing immunotherapies for osteosarcoma.
Insights
- $ostx creators is up XXX% from the previous week.
- $ostx engagements is up XXXXXX% from the previous week.
- $ostx mentions is up XXXXXX% from the previous week.
- $ostx posts created is up XXX% from the previous week.
Engagements: XXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX +308%
X Month: XXXXXX -XX%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX +164%
1-Year High: XXXXXX on 2025-02-14
1-Year Low: X on 2025-05-09
Engagements by network (24h): TikTok: X X: XXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX +218%
X Month: XXX -XX%
X Months: XXXXX +83%
X Year: XXXXX +129%
1-Year High: XXX on 2025-07-04
1-Year Low: X on 2025-05-09
Mentions by network (24h): TikTok: X X: XX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $ostx in the last XX hours which is up XXX% from X in the previous XX hours
Daily Average: XX
X Week: XX +225%
X Month: XX +25%
X Months: XXXXX +488%
X Year: XXXXX +977%
1-Year High: XXX on 2025-07-17
1-Year Low: X on 2025-05-09
The most influential creators that mention $ostx in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @OSTherapies | X | XXX | X | XX |
| @stocks_runner | X | XX | X | XX |
| @Lycanbull | X | XXXXX | X | XX |
Sentiment: XXX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Month: XXX% no change
X Months: XXX% no change
X Year: XXX% +7%
1-Year High: XXX% on 2024-12-25
1-Year Low: XX% on 2025-03-13
Most Supportive Themes:
- OST-HER2 Efficacy and Safety: (30%) Data from $OSTX Phase 2b trial reveal OST-HER2's broad efficacy across osteosarcoma patient subgroups, showing XX% 1-year EFS in 2nd+ metastatic events and a favorable safety profile compared to chemotherapy.
- OS Animal Health Spin-off: (25%) OS Animal Health is set to spin off as a standalone public company in 2026, advancing canine OST-HER2, which has received conditional approval from the USDA for canine osteosarcoma.
Most Critical Themes:
Top $ostx Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$OSTX +2.08% today as OS Therapies Announces Successful pre-Marketing Authorisation Application Meeting with UK MHRA Regarding the Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent Fully Resected Pulmonary Metastatic Osteosarcoma More Info:"
X Link @OzmosiHealth 2025-12-09T15:58Z 3018 followers, XXX engagements
"$OSTX OS Therapies Announces Successful pre-Marketing Authorisation Application Meeting with UK MHRA Regarding the Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent Fully Resected Pulmonary Metastatic Osteosarcoma"
X Link @John_Porter10 2025-12-09T13:35Z 5026 followers, XXX engagements
"$OSTX OS Therapies Announces Successful pre-Marketing Authorisation Application Meeting with UK MHRA Regarding the Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent"
X Link @MapagoTrades 2025-12-09T12:45Z XXX followers, XXX engagements
"$OSTX OS Therapies Announces Successful pre-Marketing Authorisation Application Meeting with UK MHRA Regarding the Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent Fully Resected Pulmonar"
X Link @Lycanbull 2025-12-09T12:42Z 8551 followers, XXX engagements